Emergent BioSolutions (EBS) Times Interest Earned (2011 - 2026)
Emergent BioSolutions' (EBS) quarterly Times Interest Earned came in at $0.8 in Q1 2026, down 73.18% year-on-year from $2.99 in Q1 2025, and up 150.56% quarter-over-quarter from -$1.59 in Q4 2025.
Emergent BioSolutions (EBS) Times Interest Earned (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Times Interest Earned history runs 16 years deep, the most recent figure standing at $0.8 for Q1 2026.
- On a quarterly basis, Times Interest Earned fell 73.18% year-over-year to $0.8 in Q1 2026; TTM through Mar 2026 was $0.97, a 162.35% increase from a year earlier, with the FY2025 full-year figure at $0.3, up 194.71% from the prior year.
- Times Interest Earned grew to $0.8 in Q1 2026 per EBS's latest filing, from -$1.59 in the prior quarter.
- Across five years, Times Interest Earned topped out at $7.77 in Q3 2024 and bottomed at -$12.29 in Q3 2023.
- The 5-year median for Times Interest Earned is -$1.59 (2025), against an average of -$2.52.
- Across the five-year window, Times Interest Earned slumped 1284.87% in 2022 and surged 163.23% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$4.32 in 2022, then jumped by 53.28% to -$2.02 in 2023, then soared by 68.2% to -$0.64 in 2024, then slumped by 146.96% to -$1.59 in 2025, then surged by 150.56% to $0.8 in 2026.
- Per Business Quant, the three latest EBS Times Interest Earned figures stand at $0.8 (Q1 2026), -$1.59 (Q4 2025), and $5.03 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Emergent BioSolutions | 389.77 Mn | 228.27 Mn | 84.10 Mn | 0.80 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.80 |
| Dec 31, 2025 | -1.59 |
| Sep 30, 2025 | 5.03 |
| Jun 30, 2025 | 0.05 |
| Mar 31, 2025 | 2.99 |
| Dec 31, 2024 | -0.64 |
| Sep 30, 2024 | 7.77 |
| Jun 30, 2024 | -8.62 |
| Mar 31, 2024 | 1.64 |
| Dec 31, 2023 | -2.02 |
| Sep 30, 2023 | -12.29 |
| Jun 30, 2023 | -10.24 |
| Mar 31, 2023 | -6.83 |
| Dec 31, 2022 | -4.32 |
| Sep 30, 2022 | -5.33 |
| Jun 30, 2022 | -9.78 |
| Mar 31, 2022 | 0.59 |
| Dec 31, 2021 | 39.83 |
| Sep 30, 2021 | -5.32 |
| Jun 30, 2021 | 0.83 |